Vivani Medical
VANI
42 hedge funds and large institutions have $5.84M invested in Vivani Medical in 2019 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 5 increasing their positions, 8 reducing their positions, and 7 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.02% less ownership
Funds ownership: 0.26% → 0.25% (-0.02%)
7% less funds holding
Funds holding: 45 → 42 (-3)
7% less capital invested
Capital invested by funds: $6.26M → $5.84M (-$421K)
38% less repeat investments, than reductions
Existing positions increased: 5 | Existing positions reduced: 8
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Top Buyers
| 1 |
Geode Capital Management
Boston,
Massachusetts
|
+$32.7K |
| 2 |
LPL Financial
San Diego,
California
|
+$18.3K |
| 3 |
Lido Advisors
Los Angeles,
California
|
+$10.3K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$9.25K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$2.99K |
Top Sellers
| 1 |
PVH
Psagot Value Holdings
Tel Aviv,
Israel
|
-$247K |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$133K |
| 3 |
BlackRock
New York
|
-$49.5K |
| 4 |
Bank of New York Mellon
New York
|
-$20K |
| 5 |
Millennium Management
New York
|
-$13K |
VANI Hedge Fund Activity: Q2 2019 in Review
42 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Vivani Medical (VANI) for Q2 2019, worth a combined $5.84M — down 6.7% from $6.26M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of VANI and 4 opened new positions — a net loss of 3 holders — while 8 trimmed existing stakes and 5 added.
The largest buyer was Geode Capital Management, adding an estimated $32.7K. The largest seller was Psagot Value Holdings, exiting entirely with an estimated $247K sold.
- 42 institutional investors held Vivani Medical (VANI) as of Q2 2019, down from 45 in Q1 2019.
- Funds reported $5.84M of Vivani Medical stock for Q2 2019, down 6.7% quarter-over-quarter.
- 4 funds opened new Vivani Medical positions in Q2 2019 and 7 closed out, a net change of -3 holders.
- The largest Vivani Medical buyer in Q2 2019 was Geode Capital Management, an estimated $32.7K added.
- The largest Vivani Medical seller in Q2 2019 was Psagot Value Holdings, an estimated $247K sold.
Based on aggregated 13F filings for Q2 2019.